While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Boehringer Ingelheim launches three-in-one poultry vaccine to ease operational burden on farms Wednesday, 18 June, 2025, 14 : 00 PM [IST] Our Bureau, Bengaluru Boehringer Ingelheim, a global leader in ...

Boehringer Ingelheim Pharma GmbH & Co KG has selected a third oncology drug candidate to advance into IND-enabling studies under its ongoing collaboration with Oxford Biotherapeutics Ltd.

The study, supported by Boehringer Ingelheim, included 4,000 patients from Geisinger with diabetes and/or hypertension, two prominent risk factors for CKD. Patients in the pilot group received ...

Abu Dhabi strengthens global pharma vision with Boehringer Ingelheim partnership New MoU positions UAE as rising global hub for pharmaceutical innovation Last updated: June 18, 2025 | 15:18 ...

Boehringer Ingelheim has launched its poultry vaccine in India—a single-dose, next-generation solution that protects against Bursal, Newcastle and Marek’s disease, the company said. This ...

The Lung Cancer Research Foundation (LCRF) announces today a new research collaboration with Boehringer Ingelheim creating two funding mechanisms designed to address HER2 mutations in lung cancer ...

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, one of the world's leading ...

The LCRF|Boehringer Ingelheim Team Science Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer award, is a $1.5 million, three-year award to a team of researchers whose ...

NEW YORK – The Lung Cancer Research Foundation and Boehringer Ingelheim have jointly created two funding opportunities, through which researchers exploring new treatments for HER2-mutated lung cancer ...